Free Trial

Stock Traders Purchase Large Volume of Call Options on Tenet Healthcare (NYSE:THC)

Tenet Healthcare Co. (NYSE:THC - Get Free Report) was the target of some unusual options trading activity on Tuesday. Investors bought 3,041 call options on the company. This is an increase of approximately 8% compared to the typical volume of 2,804 call options.

Insider Activity

In related news, Director Richard W. Fisher sold 2,100 shares of the stock in a transaction dated Wednesday, February 14th. The shares were sold at an average price of $88.21, for a total value of $185,241.00. Following the completion of the transaction, the director now owns 20,127 shares of the company's stock, valued at $1,775,402.67. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Richard J. Mark sold 14,000 shares of the stock in a transaction dated Tuesday, March 12th. The shares were sold at an average price of $98.98, for a total value of $1,385,720.00. Following the completion of the transaction, the director now owns 33,303 shares of the company's stock, valued at $3,296,330.94. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Richard W. Fisher sold 2,100 shares of the stock in a transaction dated Wednesday, February 14th. The stock was sold at an average price of $88.21, for a total transaction of $185,241.00. Following the completion of the transaction, the director now directly owns 20,127 shares of the company's stock, valued at approximately $1,775,402.67. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 51,268 shares of company stock valued at $4,944,810. Insiders own 0.93% of the company's stock.


Institutional Investors Weigh In On Tenet Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Nordea Investment Management AB boosted its holdings in Tenet Healthcare by 324.3% in the 4th quarter. Nordea Investment Management AB now owns 40,066 shares of the company's stock valued at $3,030,000 after purchasing an additional 30,623 shares during the period. First Eagle Investment Management LLC boosted its holdings in Tenet Healthcare by 37.3% in the 3rd quarter. First Eagle Investment Management LLC now owns 176,404 shares of the company's stock valued at $11,623,000 after purchasing an additional 47,952 shares during the period. Bleakley Financial Group LLC boosted its holdings in Tenet Healthcare by 6.0% in the 4th quarter. Bleakley Financial Group LLC now owns 91,159 shares of the company's stock valued at $6,889,000 after purchasing an additional 5,198 shares during the period. Vanguard Group Inc. boosted its holdings in Tenet Healthcare by 0.6% in the 3rd quarter. Vanguard Group Inc. now owns 10,937,483 shares of the company's stock valued at $720,671,000 after purchasing an additional 63,253 shares during the period. Finally, TD Asset Management Inc bought a new stake in Tenet Healthcare in the 3rd quarter valued at about $1,146,000. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Tenet Healthcare Trading Up 13.3 %

Shares of NYSE THC traded up $13.15 during midday trading on Tuesday, reaching $112.30. 3,866,059 shares of the stock were exchanged, compared to its average volume of 1,167,617. The business has a 50-day simple moving average of $98.38 and a two-hundred day simple moving average of $81.03. The company has a market capitalization of $11.14 billion, a price-to-earnings ratio of 19.67, a P/E/G ratio of 3.08 and a beta of 2.08. Tenet Healthcare has a 12 month low of $51.04 and a 12 month high of $112.30. The company has a debt-to-equity ratio of 4.77, a current ratio of 1.51 and a quick ratio of 1.42.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its quarterly earnings results on Thursday, February 8th. The company reported $2.68 earnings per share for the quarter, topping analysts' consensus estimates of $1.58 by $1.10. The company had revenue of $5.38 billion for the quarter, compared to analysts' expectations of $5.28 billion. Tenet Healthcare had a net margin of 2.97% and a return on equity of 26.34%. The business's quarterly revenue was up 7.8% compared to the same quarter last year. During the same period last year, the firm posted $1.96 earnings per share. As a group, equities research analysts expect that Tenet Healthcare will post 6.3 EPS for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on THC. Wells Fargo & Company raised their price objective on shares of Tenet Healthcare from $105.00 to $115.00 and gave the stock an "overweight" rating in a report on Thursday, March 28th. Barclays began coverage on shares of Tenet Healthcare in a report on Wednesday, March 6th. They set an "overweight" rating and a $113.00 price objective for the company. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Tenet Healthcare from $100.00 to $126.00 and gave the stock a "buy" rating in a report on Friday, April 12th. Wolfe Research raised shares of Tenet Healthcare from a "peer perform" rating to an "outperform" rating and set a $122.00 price target on the stock in a research note on Wednesday, March 27th. Finally, Cantor Fitzgerald reissued an "overweight" rating and set a $104.00 price target on shares of Tenet Healthcare in a research note on Wednesday, April 10th. One research analyst has rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Buy" and an average target price of $100.38.

Check Out Our Latest Research Report on THC

Tenet Healthcare Company Profile

(Get Free Report)

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Recommended Stories

Should you invest $1,000 in Tenet Healthcare right now?

Before you consider Tenet Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.

While Tenet Healthcare currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: